COVID: Inhalable and nasal vaccines could offer more durable protection than regular shots
Several mucosal vaccine candidates are being explored in pre-clinical and clinical trials. Image: Unsplash
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
COVID-19
How has the Forum navigated the global response to COVID-19?
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on COVID-19See all
Simon Nicholas Williams
May 9, 2023
Philip Clarke, Jack Pollard and Mara Violato
April 17, 2023
Rebecca A. Drummond
April 11, 2023
Laura Lebastard, Marco Matani and Roberta Serafini
March 29, 2023
Samuel J. White and Philippe B. Wilson
March 23, 2023